Advertisement

Search Results

Advertisement



Your search for James R. Jett, MD matches 1 pages

Showing 1 - 1


lung cancer

James R. Jett, MD, on Screening With Early CDT and CT

James R. Jett, MD, of National Jewish Health, discusses his study of the early CDT-Lung biomarker. His hypothesis: When used in combination with low-dose CT in screening of a high-risk population, this biomarker would increase the detection of early-stage lung cancer (Abstract MINI 12.11).

Advertisement

Advertisement




Advertisement